Back to Intelligence
#life-sciences
(2 articles)Trade Policy & Tariffs
High ImpactAug 22, 2026Tariffs Threaten Life Sciences Supply Chains: New Compliance Risks
Freshfields has identified a convergence of tariff policies and trade dynamics that pose emerging risks to life sciences companies engaged in cross-border pharmaceutical and medical device supply chai
Freshfields#tariff-policy#life-sciences#trade-risk
Risk & Disruption
High ImpactJul 24, 2026Geopolitical Mapping Critical for Pharma Supply Chain Resilience
Geopolitical tensions and shifting trade dynamics are creating unprecedented complexity in pharmaceutical supply chains, making strategic supply chain mapping an operational imperative rather than a n
Pharmaceutical Commerce#geopolitical-risk#supply-chain-mapping#life-sciences
